METHYL 1-(4-BROMOPHENYL)-4-OXOCYCLOHEXANECARBOXYLATE, 95.0%, 10g

6,6'-bis((S)-4-benzyl-4,5-dihydrooxazol-2-yl)-2,2'-bipyridine, 95%, 250mg

7-Chloro-1-methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione, 98%, 100mg

(S)-2-Amino-1-phenylethanol, 97.0%, 5g

1-Bromo-5-chloro-2-methyl-3-nitrobenzene, 95.0%, 5g

1-((4-Chlorophenyl)(phenyl)methyl)-4-(3-methylbenzyl)piperazine dihydrochloride, 95.0%, 500g

1-Bromo-2-nitro-4-(trifluoromethoxy)benzene, 95.0%, 1g

2-Bromovaleric acid, 98.0%, 25g

4-Fluorophenylhydrazine Hydrochloride>97.0%(HPLC)(T)25g

4-(1,2-Dihydroxyethyl)benzene-1,2-diol, 97%, 5mg

3-Methoxythiobenzamide, 98.0%, 25g

4-CHLORO-2-IODO-1-METHYL-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 500mg

2-amino-4-chlorobenzoic acid, min. 98%, for biochemistry, 10 g, plastic packaging.